GLENMARK PHARMACEUTICALS
Back to Income Statement
|
GLENMARK PHARMACEUTICALS Last 5 Year Appropriations History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Appropriations | ₹7,955 Cr | ₹9,508 Cr | ₹8,175 Cr | ₹7,300 Cr | ₹6,391 Cr |
What is the latest Appropriations of GLENMARK PHARMACEUTICALS ?
| Year | Appropriations |
|---|---|
| Mar2025 | ₹7,955 Cr |
| Mar2024 | ₹9,508 Cr |
| Mar2023 | ₹8,175 Cr |
| Mar2022 | ₹7,300 Cr |
| Mar2021 | ₹6,391 Cr |
How is Appropriations of GLENMARK PHARMACEUTICALS Trending?
| Years | Appropriations | % Change | |
|---|---|---|---|
| Mar2025 | ₹7,955 Cr | -16.33 | |
| Mar2024 | ₹9,508 Cr | 16.30 | |
| Mar2023 | ₹8,175 Cr | 12.00 | |
| Mar2022 | ₹7,300 Cr | 14.22 | |
| Mar2021 | ₹6,391 Cr | - | |
Compare Appropriations of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹62,620.2 Cr | -1.9% | -2.3% | 1.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹470,270.0 Cr | -1.5% | 2.5% | 14.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹222,224.0 Cr | 7.4% | 22.2% | 26.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,325.0 Cr | 3.1% | 4.3% | 38.5% | Stock Analytics | |
| CIPLA | ₹117,139.0 Cr | -1.6% | -1.4% | -6.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,876.6 Cr | 1.5% | -15.2% | -9.1% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | -1.9% |
-2.3% |
1.8% |
| SENSEX | 2.2% |
0.9% |
-3.7% |
You may also like the below Video Courses